IL7R and type 1 diabetes mellitus: Our study is one of very few reports addressing the issue of CD4+CD25+CD127− T-cells in long-lasting T1D and, notably, in the context of metabolic and early vascular consequences of T1D in young population without clinically apparent cardiovascular disease.